Published in Scand J Immunol on July 01, 1983
Selective inhibition of human diploid fibroblast collagen synthesis by interferons. J Clin Invest (1984) 1.70
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years. Hepatology (1990) 6.53
Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med (2000) 3.74
Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology (1998) 3.13
A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med (1999) 2.86
Haemochromatosis and HLA-H. Nat Genet (1996) 2.81
Identification of homozygous hemochromatosis subjects by measurement of hepatic iron index. Hepatology (1990) 2.30
Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology (1986) 2.30
Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study. Eur Respir J (2011) 2.21
Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol (1990) 2.01
Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am J Hum Genet (2000) 1.89
EASL International Consensus Conference on Haemochromatosis. J Hepatol (2000) 1.76
Hereditary hemochromatosis: gene discovery and its implications for population-based screening. JAMA (1998) 1.73
Normal serum ferritin concentrations in precirrhotic hemochromatosis. N Engl J Med (1976) 1.68
Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis. Lancet (2005) 1.68
A novel variant genotype C of hepatitis B virus identified in isolates from Australian Aborigines: complete genome sequence and phylogenetic relatedness. J Gen Virol (2001) 1.67
Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology (1999) 1.58
The Australian Tobacco Research Foundation. Med J Aust (1988) 1.58
Suppression of the asthmatic phenotype by ultraviolet B-induced, antigen-specific regulatory cells. Clin Exp Allergy (2007) 1.54
Improved growth and clinical, nutritional, and respiratory changes in response to nutritional therapy in cystic fibrosis. J Pediatr (1980) 1.52
Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. J Clin Invest (1983) 1.52
Idiopathic unconjugated hyperbilirubinemia (Gilbert's syndrome). A study of 42 families. N Engl J Med (1967) 1.48
Localization of the hemochromatosis gene close to D6S105. Am J Hum Genet (1993) 1.46
An assessment of red cell survival in idiopathic unconjugated hyperbilirubinaemia (Gilbert's syndrome) by the use of radioactive diisopropylfluorophosphate and chromium. Australas Ann Med (1967) 1.46
Comparison of four methods for quantitative measurement of hepatitis B viral DNA. J Hepatol (1996) 1.45
Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma protein binding. Gut (1972) 1.41
Population screening for HFE-associated haemochromatosis: should we have to pay for our genes? Intern Med J (2001) 1.40
Diagnosis of hemochromatosis in young subjects: predictive accuracy of biochemical screening tests. Gastroenterology (1984) 1.37
Distribution of transferrin saturation in an Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology (1998) 1.35
Iron and coronary heart disease. BMJ (1993) 1.35
Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous for the C282Y mutation. Gastroenterology (1998) 1.35
Cohort study of internal malignancy in genetic hemochromatosis and other chronic nonalcoholic liver diseases. J Natl Cancer Inst (1985) 1.31
Enhanced drug metabolism in cigarette smokers. Br Med J (1976) 1.31
Factors affecting the concentrations of ferritin in serum in a healthy Australian population. Clin Chem (1990) 1.30
Hemochromatosis: 1980 update. Gastroenterology (1980) 1.29
Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention. Gastroenterology (1990) 1.29
Haemochromatosis after the discovery of HFE ("HLA-H") Gut (1997) 1.28
Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Intern Med (1998) 1.28
Intestinal mucosal uptake of iron and iron retention in idiopathic haemochromatosis as evidence for a mucosal abnormality. Gut (1970) 1.27
Guillain Barré syndrome during the pre-icteric phase of acute type B viral hepatitis. Aust N Z J Med (1975) 1.26
Differentiation between heterozygotes and homozygotes in genetic hemochromatosis by means of a histological hepatic iron index: a study of 192 cases. Hepatology (1993) 1.25
Desialylated transferrin as a serological marker of chronic excessive alcohol ingestion. Lancet (1987) 1.23
Human isoferritins: organ specific iron and apoferritin distribution. Br J Haematol (1975) 1.23
Demonstration of previously undetected hepatitis B viral determinants in an Australian Aboriginal population by monoclonal anti-hbs antibody radioimmunoassays. Lancet (1982) 1.23
Is all genetic (hereditary) hemochromatosis HLA-associated. Ann N Y Acad Sci (1988) 1.22
Abnormality in tissue isoferritin distribution in idiopathic haemochromatosis. Nature (1974) 1.19
Basic pathogenic mechanisms operating in experimental models of acute anterior uveitis. Immunol Cell Biol (1998) 1.18
Lipid peroxidation in hepatic steatosis in humans is associated with hepatic fibrosis and occurs predominately in acinar zone 3. J Gastroenterol Hepatol (2001) 1.17
Iron storage disorders of the liver. Gastroenterology (1974) 1.17
Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol (1997) 1.16
The water-soluble components of the essential oil of Melaleuca alternifolia (tea tree oil) suppress the production of superoxide by human monocytes, but not neutrophils, activated in vitro. Inflamm Res (2001) 1.16
Transferrin receptor distribution and regulation in the rat small intestine. Effect of iron stores and erythropoiesis. Gastroenterology (1990) 1.15
Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet (1995) 1.15
Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis. Am J Hum Genet (1995) 1.14
Concordance of iron storage in siblings with genetic hemochromatosis: evidence for a predominantly genetic effect on iron storage. Hepatology (1993) 1.14
Recurrent hepatitis in patients receiving multiple halothane anesthetics for radium treatment of carcinoma of the cervix uteri. Gastroenterology (1970) 1.13
Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes. Clin Pharmacol Ther (1979) 1.13
Detection of male DNA in the liver of female patients with primary biliary cirrhosis. J Hepatol (2000) 1.13
Cirrhosis of the liver. A comparative study of the four major aetiological groups. Med J Aust (1971) 1.12
Effect of hemochromatosis genotype and lifestyle factors on iron and red cell indices in a community population. Clin Chem (2001) 1.11
Evidence that "myofibroblast-like" cells are the cellular source of capsular collagen in hepatocellular carcinoma. J Hepatol (1997) 1.09
Effects of alcohol consumption on indices of iron stores and of iron stores on alcohol intake markers. Alcohol Clin Exp Res (2001) 1.09
Red cell survival in experimental cholestatic cholestatic jaundice. Br J Haematol (1968) 1.09
HLA typing in idiopathic hemochromatosis: distinction between homozygotes and heterozygotes with biochemical expression. Hepatology (1981) 1.08
A novel mutation in ferroportin1 is associated with haemochromatosis in a Solomon Islands patient. Gut (2003) 1.08
Wilson's disease in an Australian aborigine. J Gastroenterol Hepatol (1991) 1.07
Iron overload. Semin Hematol (1982) 1.07
Red cell survival after Heterograft valve surgery. Br Med J (1968) 1.06
Sertraline treatment of interferon-alfa-induced depressive disorder. Med J Aust (2000) 1.05
Tea tree oil reduces the swelling associated with the efferent phase of a contact hypersensitivity response. Inflamm Res (2002) 1.05
Idiopathic haemochromatosis in the Australian population: HLA linkage and recessivity. Hum Immunol (1981) 1.05
Is ultrasonography useful in the assessment of diffuse parenchymal liver disease? Gastroenterology (1985) 1.05
The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis. Hepatology (1986) 1.04